Abstract: An ultrasound scanning control method applied to an ultrasound scanning device is provided. The ultrasound scanning device includes an execution mechanism. The execution mechanism includes a mechanical arm and a probe. The ultrasound scanning control method includes: controlling the mechanical arm to drive the probe to move according to a set scanning trajectory; and controlling the probe to collect an ultrasound image. A target region is identified from the collected ultrasound image. The scanning trajectory is adjusted when a position of the target region in the ultrasound image is not a predetermined position, and the mechanical arm is controlled to drive the probe to move according to the adjusted scanning trajectory.

Abstract: A container designed to store dehydrated biological material under a controlled atmosphere, in particular at ambient temperature, and more particularly DNA, includes an envelope (12) that is made of a gas-tight material. The envelope (12) is made of a material that is metal and cylindrical in shape, sealed at one end, and it includes a stopper (16) that is designed to be connected in an airtight manner to the envelope.

Abstract: A container designed to store dehydrated biological material under a controlled atmosphere, in particular at ambient temperature, and more particularly DNA, includes an envelope (12) that is made of a gas-tight material. The envelope (12) is made of a material that is metal and cylindrical in shape, sealed at one end, and it includes a stopper (16) that is designed to be connected in an airtight manner to the envelope.

Abstract: A method for the preparation of a sample of biological material in a container for the purpose of its storage, its recovery, and its subsequent use, includes the succession of the following stages: preparation of the biological material with solubilization, quality control of the thus prepared biological material, labeling of the container with recording of the identification, introduction of this biological material into the container, dehydration of the biological material, sealing of the container, sealing test, and placement in a storage station. A method for using the prepared sample is also described.

Abstract: Disclosed is a method for screening an immune modulator. More specifically, disclosed is a method of screening an immune modulator, an anticancer agent and an agent for treating autoimmune diseases, which regulate the cell surface expression level of gp96, using the binding of the region of amino acids 54-192 of AIMP1 to the region of amino acids 699-799 of AIMP1, set forth in SEQ ID NO: 18. Also disclosed is a method of diagnosing autoimmune diseases using the binding.

Abstract: This invention relates to compounds of Formula I having an aziridine-2-carboxylic group and a menthol group, a process for preparing such compounds, a method for obtaining optically active aziridine-2-carboxylate derivatives by optical resolution of such compounds, and optically active aziridine-2-carboxylate derivatives obtained by the same method: wherein R1 is hydrogen; alkyl; cycloalkyl; 4-chlorophenyl; 4-methoxyphenyl; s-triazinyl or pyridinyl acyl; benzyl; hydrocarbon residue which may be substituted with a substituent selected from the group consisting of hydroxy, alkoxy, dialkylamino, phenyl, 4-chlorophenyl and 4-methoxyphenyl; 2,4-dimethoxyphenyl; substituted phenyl including (1R)-phenylethyl or (1S)-phenylethyl. Preferences are given to (1R)-phenylethyl and (1S)-phenylethyl. Menthol is selected from the group consisting of (+)-menthol and (?)-menthol.

Abstract: The present invention relates to an immunological enhancement agent, more particularly, to an immunological enhancement agent comprising peptide having an amino acid sequence represented by SEQ ID NO:1 to SEQ ID NO:3 as an effective component. The peptides according to the present invention comprising the N-terminal domain of the p43 protein have excellent cytokine activity to improve an immune response so that they can be used as an effective immunological enhancement agent.

Abstract: The present invention relates to an immunological enhancement agent, more particularly, to an immunological enhancement agent comprising peptide having an amino acid sequence represented by SEQ ID NO:1 to SEQ ID NO:3 as an effective component.